Medindia

X

Vion Pharmaceuticals Issues Management Statement Regarding Trading Volume of Company's Common Stock

Monday, January 25, 2010 General News J E 4
Advertisement

COMPANY CONTACT:

Vion Pharmaceuticals, Inc.

Alan Kessman, Chief Executive Officer

Howard B. Johnson, President & CFO

(203) 498-4210

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
NOVAVAX to Present at Phacilitate Vaccine Forum Wa...
S
Intercept Pharmaceuticals Raises $25 Million Serie...